Events

Clinical Trial Flexibility and Customization Needs that are Required by Biotechs and Next Generation Therapies

Join Catalyst Oncology's Vice President of Oncology Drug Development, Andrew Zupnick, PhD, our Executive Director of Oncology Drug Development, Susan Albert, alongside X4 Pharmaceuticals' Senior Vice President of Development Operations, Carrie Melvin, and Medidata Solutions' Senior Director, Ted Kirby, in this DIA-hosted webinar to hear how we implement our core value of flexibility into your clinical trials.



3 December 2020 | 11:00 AM - 12:00 PM ET



Virtual

Schedule A Meeting

Register

ASH 2020

The 62 annual ASH meeting exposition will take place this virtually year in light of health concerns and travel restrictions. Catalyst will be exhibiting at the premier event in malignant and non-malignant hematology. We look forward to connecting with you at the world’s most comprehensive hematology event of the year, and welcome the opportunity to learn invaluable information and gain priceless experience at the 62 annual meeting. For more information on ASH, or to schedule a meeting with Catalyst, click the buttons below.



5 - 8 December 2020



Virtual

Schedule A Meeting

Register

“The Catalyst staff is always friendly, knowledgeable, and professional and responds quickly to all questions and issues. I have worked with many other CRAs and project managers placed by Catalyst, and they all are very seasoned, knowledgeable individuals with a team attitude.”